Modulatory effects of ayahuasca on personality structure in a traditional framework
This mixed-design study (n=48) finds significant increases in agreeableness and reductions in neuroticism post-ayahuasca administration (n=24), sustained at 6-month follow-up, with trait level increases in openness also observed at follow-up. The study also reports an association between greater perceived mystical experience and increased reductions in neuroticism.
Authors
- Netzband, N.
- Ruffell, S.
- Linton, &. S.
Published
Abstract
Ayahuasca is a psychoactive plant brew containing dimethyltryptamine (DMT) and monoamine oxidase inhibitors (MAOIs). It originates from the Amazon basin, where it is used primarily for ceremonial purposes. Ayahuasca tourists are now entering certain communities seeking alternative physical or psychological healing, as well as spiritual growth.
Rationale
Recent evidence has shown that the similar acting psychedelic compound, psilocybin, facilitated long-term increases in trait openness following a single administration.
Objectives
This paper assesses the impact of ayahuasca on personality in a traditional framework catering for ayahuasca tourists.
Method
Within a mixed design, we examined the effect of ayahuasca on participants’ personality (measured by the NEO Personality Inventory 3 questionnaire) across time (pre- to post-ayahuasca administration, and 6-month follow-up), relative to a comparison group (who did not ingest ayahuasca).
Results
The results demonstrated significant increases in agreeableness pre- and post-ayahuasca administration and significant reductions in neuroticism in 24 participants, relative to the comparison group. Both of these changes were sustained at 6-month follow-up, and trait level increases were also observed in openness at this stage. Additionally, greater perceived mystical experience (measured using the Mystical Experience Questionnaire 30) was associated with increased reductions in neuroticism.
Conclusions
These findings, which indicate a positive mediating effect of ayahuasca on personality, support the growing literature suggesting potential therapeutic avenues for serotonergic psychedelics.
Research Summary of 'Modulatory effects of ayahuasca on personality structure in a traditional framework'
Introduction
Netzband and colleagues frame ayahuasca as an Amazonian plant brew containing DMT plus MAO inhibitors, used traditionally in ceremonial contexts and increasingly by international ‘ayahuasca tourists’. The introduction notes mechanistic links between serotonergic 5-HT2A receptor agonism and alterations in brain networks such as the default mode network, and it summarises prior human and animal evidence that single or occasional administrations of serotonergic psychedelics (including psilocybin and ayahuasca) can produce rapid antidepressant effects and longer-term changes in mood, cognition and some personality domains. Building on earlier studies that reported increases in openness and other trait-level changes after psychedelics, the study aimed to evaluate whether participation in a 12-day, Shipibo-style ayahuasca retreat adapted for tourists would modulate personality structure. The investigators set out to measure short-term (post-retreat) and six-month follow-up changes in Big Five personality domains (using the NEO-PI3), and to test whether the intensity of perceived mystical experience (MEQ30) related to any personality changes. The setting was an indigenous Shipibo community–based retreat in the Peruvian Amazon that caters to international participants.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- APA Citation
Netzband, N., Ruffell, S., Linton, S., Tsang, W. F., & Wolff, T. (2020). Modulatory effects of ayahuasca on personality structure in a traditional framework. Psychopharmacology, 237(10), 3161-3171. https://doi.org/10.1007/s00213-020-05601-0
References (25)
Papers cited by this study that are also in Blossom
Barbosa, P., Strassman, R. J., da Silveira, D. X. et al. · Comprehensive Psychiatry (2016)
Barrett, F. S., Griffiths, R. R. · Current Topics in Behavioral Neurosciences (2017)
Bouso, J. C., González, D., Fondevila, S. et al. · PLOS ONE (2012)
Bouso, J. C., Fábregas, J. M., Antonijoan, R. M. et al. · Psychopharmacology (2013)
Rodríguez-Fornells, A., Ribeiro, S., Sanches, R. F. et al. · European Neuropsychopharmacology (2015)
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
De Araujo, D. B., Ribeiro, S., Cecchi, G. A. et al. · Human Brain Mapping (2011)
Dos Santos, R. G., Balthazar, F. M., Bouso, J. C. et al. · Journal of Psychopharmacology (2016)
Dos Santos, R. G., Hallak, J. E., Bouso, J. C. · Therapeutic Advances in Psychopharmacology (2017)
Show all 25 referencesShow fewer
Erritzoe, D., Roseman, L., Nour, M. R. et al. · Acta Psychiatrica Scandinavica (2018)
Fábregas, J. M., González, D., Fondevila, S. et al. · Drug and Alcohol Dependence (2010)
Gable, R. S. · Addiction (2006)
Hartogsohn, I. · Journal of Psychopharmacology (2016)
Maclean, K. A., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2011)
MacLean, K. A., Leoutsakos, J. S., Johnson, M. W. et al. · Journal for the Scientific Study of Religion (2012)
McKenna, D. · ACS Chemical Neuroscience (2004)
Mithoefer, A. T., Mithoefer, M. C., Feduccia, A. A. et al. · Lancet Psychiatry (2018)
Osório, F. L., Sanches, R. F., Macedo, L. et al. · brazilian Journal of Psychiatry (2015)
Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Riba, J., Valle, M., Urbano, G. et al. · Journal of Pharmacology and Experimental Therapeutics (2003)
Sanches, R. F., Osório, F. L., Dos Santos, R. G. et al. · Journal of Clinical Psychopharmacology (2016)
Santos, R. G., Landeira-Fernandez, J., Strassman, R. J. et al. · Journal of Ethnopharmacology (2007)
Thomas, G., Lucas, P., Rielle Capler, N. et al. · Current Drug Abuse Reviews (2013)
Cited By (27)
Papers in Blossom that reference this study
Bonomo, Y. A., Norman, A. F., Collins, L. et al. · Frontiers in Psychiatry (2025)
Pagni, B. A., Halman, A., Sarris, J. et al. · Journal of Psychoactive Drugs (2025)
Godfrey, K., Weiss, B., Zhang, X. et al. · Neuroscience Applied (2025)
Pagni, B. A., Zeifman, R. J., Mennenga, S. E. et al. · American Journal of Psychiatry (2025)
Gordon, A. R., Carrithers, B. M., Pagni, B. A. et al. · Research Square (2024)
Weiss, B., Sleep, C., Beller, N. et al. · Journal of Psychedelic Studies (2023)
Weiss, B., Ginige, I., Shannon, L. et al. · Psychological Medicine (2023)
Kangaslampi, S. · Journal of Psychedelic Studies (2023)
Weiss, B., Sleep, C., Miller, J. D. et al. · Journal of Personality Disorders (2023)
Perkins, D., Ruffell, S. G. D., day, K. et al. · Frontiers in Neuroscience (2023)
Show all 27 papersShow fewer
Perkins, D., Pagni, B. A., Sarris, J. et al. · Frontiers in Pharmacology (2022)
Herrmann, Z., Earleywine, M., De Leo, J. et al. · Journal of Psychoactive Drugs (2022)
Ruffell, S. G. D., Gandy, S., Tsang, W. et al. · Psyarxiv (2022)
Aharon-Almagor, A., Barrett, F. S. · Research Square (2022)
Gandy, S. · Journal of Psychedelic Studies (2022)
Ramaekers, J. G. · Psychopharmacology (2022)
Hadar, A., David, J., Shalit, N. et al. · Journal of Psychoactive Drugs (2022)
Nygart, V., Pommerencke, L. M., Carhart-Harris, R. L. et al. · Frontiers in Psychology (2021)
Nichols, C. D., Wiatr, K., Figiel, M. et al. · Journal of Neurochemistry (2021)
van Oorsouw, K., Uthaug, M. V., Mason, N. L. et al. · Journal of Psychedelic Studies (2021)
Rodríguez Arce, J. M., Winkelman, M. J. · Frontiers in Psychology (2021)
McGovern, H., Leptourgos, P., Hutchinson, B. et al. · Psyarxiv (2021)
Castelhano, J. M., Lima, G. M., Teixeira, M. et al. · Frontiers in Pharmacology (2021)
Ruffell, S. G. D., Netzband, N., Tsang, W. et al. · Frontiers in Psychiatry (2021)
Weiss, B., Miller, J. D., Carter, N. T. et al. · Scientific Reports (2021)
Nichols, D. E., Walter, H. · Pharmacopsychiatry (2020)
Gandy, S., Forstmann, M., Carhart-Harris, R. L. et al. · Health Psychology Open (2020)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.